Dollars for Docs
How Industry Dollars Reach Your Doctors
This database was last updated in October 2019 and should only be used as a historical snapshot. Newer data is available at the Centers for Medicare and Medicaid Services Open Payments site.
PETER C ENZINGER
Listed Specialty: Medical Oncology
44 BINNEY ST, DANA-FARBER CANCER INST, BOSTON, MA, 02115-6013
MR. PETER ENZINGER,
Yearly Payment Breakdown:
2018 Payments At a Glance
15
payments
$11,885
payment total
4
companies paid this doctor
Payment Calendar in 2018
This doctor received a payment on days in 2018.
Each box below represents a single day during the disclosure period. A gray box indicates no payments. The darker the color, the more payments a doctor received that day.
2018
Types of Payments in 2018
| Category | Payments | Payment Value |
|---|---|---|
Consulting |
4 | $10,357 |
Travel and Lodging |
4 | $1,035 |
Food and Beverage |
7 | $493 |
Drugs & Devices in 2018
Totals listed below account for all payments from that mention this product. Beginning in 2016, the government began classifying products as drugs, devices, biologics or medical supplies. Below, you will see drugs (drugs and biologics) and devices (devices and medical supplies). If a payment record mentions more than one product, the entire value will be included in each of those products. When no products are listed, they are not included in the list below.
| Product Name | Product Type | Payments† |
|---|---|---|
Payments with no listed product |
N/A |
$5,524 |
KEYTRUDA |
drug |
$3,539 |
ABRAXANE |
drug |
$2,579 |
CYRAMZA |
drug |
$135 |
TISLELIZUMAB |
drug |
$109 |
| † May not add up to dollar total at top of page, since a payment record may not be associated with any product or can be associated with several products. | ||
Payment Details in 2018
| When | How Much | Related To | What For | From | Third Party Payee |
|---|---|---|---|---|---|
| Mar 23, 2018 | $3,500 | KEYTRUDA | Consulting | MERCK SHARP & DOHME CORPORATION | |
| Aug 23, 2018 | $3,000 | No Listed Product | Consulting | LILLY USA, LLC | National Comprehensive Cancer Network |
| Jan 20, 2018 | $2,525 | ABRAXANE | Consulting | CELGENE CORPORATION | |
| Dec 6, 2018 | $1,332 | No Listed Product | Consulting | LILLY USA, LLC | National Comprehensive Cancer Network |
| Jul 26, 2018 | $523 | No Listed Product | Travel and Lodging | LILLY USA, LLC | National Comprehensive Cancer Network |
| Aug 1, 2018 | $278 | No Listed Product | Travel and Lodging | LILLY USA, LLC | National Comprehensive Cancer Network |
| Aug 1, 2018 | $167 | No Listed Product | Food and Beverage | LILLY USA, LLC | National Comprehensive Cancer Network |
| Aug 23, 2018 | $119 | No Listed Product | Travel and Lodging | LILLY USA, LLC | National Comprehensive Cancer Network |
| Jan 17, 2018 | $115 | CYRAMZA | Travel and Lodging | ELI LILLY AND COMPANY | |
| Jan 20, 2018 | $109 | TISLELIZUMAB | Food and Beverage | CELGENE CORPORATION | |
| Aug 23, 2018 | $105 | No Listed Product | Food and Beverage | LILLY USA, LLC | National Comprehensive Cancer Network |
| Jan 18, 2018 | $39 | KEYTRUDA | Food and Beverage | MERCK SHARP & DOHME CORPORATION | |
| Jan 20, 2018 | $27 | ABRAXANE | Food and Beverage | CELGENE CORPORATION | |
| Jan 20, 2018 | $27 | ABRAXANE | Food and Beverage | CELGENE CORPORATION | |
| Jan 17, 2018 | $20 | CYRAMZA | Food and Beverage | ELI LILLY AND COMPANY |
See this doctor’s Open Payments page →
Note: We have made some effort to normalize the data and eliminate duplicates, but the data is primarily as it has been reported by the companies to the Centers for Medicare and Medicaid Services. To purchase the normalized data, please visit the ProPublica Data Store. If you spot an error, please let us know at [email protected].
This site includes data published by the Centers for Medicare and Medicaid Services on June 28, 2019.